piracetam has been researched along with dm 232 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dei, S; Ghelardini, C; Guandalini, L; Manetti, D; Martini, E; Melchiorre, M; Norcini, M; Pagella, S; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
Bartolucci, G; Dei, S; Di Cesare Mannelli, L; Floriddia, E; Ghelardini, C; Guandalini, L; Malik, R; Manetti, D; Martino, MV; Melani, F; Orlandi, F; Romanelli, MN; Teodori, E | 1 |
Bartolucci, G; Dei, S; Di Cesare Mannelli, L; Ghelardini, C; Guandalini, L; Manetti, D; Martino, MV; Menicatti, M; Romanelli, MN; Teodori, E | 1 |
Bartolini, A; Bellucci, C; Dei, S; Galeotti, N; Ghelardini, C; Gualtieri, F; Manetti, D; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
4 other study(ies) available for piracetam and dm 232
Article | Year |
---|---|
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
Topics: Animals; Avoidance Learning; Data Interpretation, Statistical; Drug Design; Mice; Nootropic Agents; Piperazines; Pyrroles; Recognition, Psychology | 2008 |
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
Topics: Amnesia; Animals; Avoidance Learning; Mice; Nootropic Agents; Piperazines; Pyrroles; Stereoisomerism; Structure-Activity Relationship | 2015 |
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.
Topics: Animals; Avoidance Learning; Carbon-13 Magnetic Resonance Spectroscopy; Cognition; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Mice; Nootropic Agents; Piperazines; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization | 2017 |
Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents.
Topics: Adrenergic alpha-Agonists; Amnesia; Animals; Avoidance Learning; Baclofen; Clonidine; Dose-Response Relationship, Drug; Drug Design; GABA Agonists; Mecamylamine; Mice; Molecular Structure; Muscarinic Antagonists; Nicotine; Nootropic Agents; Piperazines; Piracetam; Pyrroles; Scopolamine | 2000 |